1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Gordon Mills, MD, PhD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AMTEC IIT: Phase 2 Multiarm Study in TNBC Biopsy, Capivasertib, Ceralasertib - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 2 | Terminated | Gordon Mills, MD, PhD | 24 | 2018-12-12 | 2026-02-25 |
Triple Negative Breast Neoplasms (1)
AZD 6244 (1) · Biopsy (1) · Disulfides (1) · Immunoglobulin G (1) · capivasertib (1) · ceralasertib (1) · durvalumab (1) · olaparib (1)
United States (1)